Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AKT isoforms have distinct hippocampal expression and roles in synaptic plasticity
Josien Levenga, Helen Wong, Ryan Milstead, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Altered Insulin Signaling in Alzheimer’s Disease Brain – Special Emphasis on PI3K-Akt Pathway
Sami Gabbouj, Simo Ryhänen, Mikael Marttinen, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 318
Neuron-Derived Estrogen Regulates Synaptic Plasticity and Memory
Yujiao Lu, Gangadhara R. Sareddy, Jing Wang, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 15, pp. 2792-2809
Open Access | Times Cited: 178
Astrocytes: a double-edged sword in neurodegenerative diseases
Yuqing Yan, Cun-Gen Ma, Zhibin Ding, et al.
Neural Regeneration Research (2021) Vol. 16, Iss. 9, pp. 1702-1702
Open Access | Times Cited: 141
Apoptotic Pathways and Alzheimer’s Disease: Probing Therapeutic Potential
Vivek Sharma, Thakur Gurjeet Singh, Shareen Singh, et al.
Neurochemical Research (2021) Vol. 46, Iss. 12, pp. 3103-3122
Closed Access | Times Cited: 139
Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress
Saikat Dewanjee, Pratik Chakraborty, Hiranmoy Bhattacharya, et al.
Free Radical Biology and Medicine (2022) Vol. 193, pp. 134-157
Closed Access | Times Cited: 131
Glucose metabolic crosstalk and regulation in brain function and diseases
Shuai Zhang, Brittany Bolduc Lachance, Mark P. Mattson, et al.
Progress in Neurobiology (2021) Vol. 204, pp. 102089-102089
Open Access | Times Cited: 116
Brain-derived estrogen and neural function
Darrell W. Brann, Yujiao Lu, Jing Wang, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 793-817
Open Access | Times Cited: 97
Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function
Zoe Arvanitakis, Hoau‐Yan Wang, Ana W. Capuano, et al.
Annals of Neurology (2020) Vol. 88, Iss. 3, pp. 513-525
Open Access | Times Cited: 82
Lemon essential oil ameliorates age-associated cognitive dysfunction via modulating hippocampal synaptic density and inhibiting acetylcholinesterase
Bonan Liu, Jiayuan Kou, Fuyan Li, et al.
Aging (2020) Vol. 12, Iss. 9, pp. 8622-8639
Open Access | Times Cited: 79
Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains
Zheng Shen, Zhengyang Li, Mengting Yu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114206-114206
Open Access | Times Cited: 33
Hot Spots for the Use of Intranasal Insulin: Cerebral Ischemia, Brain Injury, Diabetes Mellitus, Endocrine Disorders and Postoperative Delirium
А. О. Шпаков, И. И. Зорина, К. В. Деркач
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3278-3278
Open Access | Times Cited: 30
Akt signaling pathway: a potential therapy for Alzheimer’s disease through glycogen synthase kinase 3 beta inhibition
Joshua Limantoro, Bryan Gervais de Liyis, Jane Carissa Sutedja
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2023) Vol. 59, Iss. 1
Open Access | Times Cited: 27
Insulin effects on core neurotransmitter pathways involved in schizophrenia neurobiology: a meta-analysis of preclinical studies. Implications for the treatment
Andrea de Bartolomeis, Giuseppe De Simone, Michele De Prisco, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2811-2825
Open Access | Times Cited: 24
Brain Microenvironment-Remodeling Nanomedicine Improves Cerebral Glucose Metabolism, Mitochondrial Activity and Synaptic Function in A Mouse Model of Alzheimer’s Disease
Elliya Park, Chunsheng He, Azhar Z. Abbasi, et al.
Biomaterials (2025), pp. 123142-123142
Open Access | Times Cited: 1
Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia
Radhika Chadha, James H. Meador‐Woodruff
Neuropsychopharmacology (2020) Vol. 45, Iss. 6, pp. 1059-1067
Open Access | Times Cited: 60
Enhancing mitochondrial activity in neurons protects against neurodegeneration in a mouse model of multiple sclerosis
Sina C. Rosenkranz, Artem Shaposhnykov, Simone Träger, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 56
Hydrophobic tag tethering degrader as a promising paradigm of protein degradation: Past, present and future perspectives
Si Ha, Jiacheng Zhu, Hua Xiang, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 8, pp. 109192-109192
Closed Access | Times Cited: 18
Akt activation ameliorates deficits in hippocampal-dependent memory and activity-dependent synaptic protein synthesis in an Alzheimer’s disease mouse model
Reddy Peera Kommaddi, Ruturaj Gowaikar, P A Haseena, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 2, pp. 105619-105619
Open Access | Times Cited: 8
Therapeutic potential of mangiferin in the treatment of various neuropsychiatric and neurodegenerative disorders
Vaibhav Walia, Sushil K. Chaudhary, Neeraj Kumar Sethiya
Neurochemistry International (2020) Vol. 143, pp. 104939-104939
Closed Access | Times Cited: 42
Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease
Kamran Tariq, Bryan W. Luikart
Exploration of Neuroprotective Therapy (2021) Vol. 1, Iss. 2
Open Access | Times Cited: 34
AKT ISOFORMS-AS160-GLUT4: The defining axis of insulin resistance
Medha Sharma, Chinmoy Sankar Dey
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 4, pp. 973-986
Closed Access | Times Cited: 33
Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells
Fang Xu, Xin Zhang, Zhipeng Chen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 20, pp. 14032-14048
Closed Access | Times Cited: 26
Selective vulnerability of hippocampal CA1 and CA3 pyramidal cells: What are possible pathomechanisms and should more attention be paid to the CA3 region in future studies?
Anne‐Marie Einenkel, Aida Salameh
Journal of Neuroscience Research (2023) Vol. 102, Iss. 1
Open Access | Times Cited: 15
A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity‐dependent synaptic and microglial transcriptomic changes in a late‐stage Alzheimer's mouse model
Amira Latif‐Hernandez, Tao Yang, Robert R. Butler, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 7, pp. 4434-4460
Open Access | Times Cited: 5
Akt3-Mediated Protection Against Inflammatory Demyelinating Disease
Juwen C. DuBois, Alex Ray, Ross C. Gruber, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top